Literature DB >> 12482733

Parathyroid hormone as a therapeutic agent.

Bruce H Mitlak1.   

Abstract

Recent advances in the use of parathyroid hormone as a therapeutic agent include a controlled trial that assessed vertebral and non-vertebral fracture risk reduction in women, trials in men, and assessment of treatment on cortical and trabecular bone structure. The occurrence of osteosarcoma in long-term toxicology studies in rats is briefly reviewed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12482733     DOI： 10.1016/s1471-4892(02)00208-4

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


  3 in total

1.  Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation.

Authors:  Sylvia C van Buul-Offers; Jeske J Smink; Ria Gresnigt; Nicole Hamers; Joost Koedam; Marcel Karperien
Journal:  Pediatr Nephrol       Date:  2005-02-02       Impact factor: 3.714

Review 2.  Potential applications of pulsating joint loading in sports medicine.

Authors:  Ping Zhang; Kazunori Hamamura; Hiroki Yokota; George M Malacinski
Journal:  Exerc Sport Sci Rev       Date:  2009-01       Impact factor: 6.230

3.  The first biosimilar approved for the treatment of osteoporosis: results of a comparative pharmacokinetic/pharmacodynamic study.

Authors:  I Takács; E Jókai; D E Kováts; I Aradi
Journal:  Osteoporos Int       Date:  2018-10-24       Impact factor: 4.507
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.